Besides, baicalein, a naturally occurring compound, has been shown to upregulate FOXO1 and thus enhance the expression of bone turnover markers and extracellular matrix mineralization, thereby ameliorating glucocorticoid-induced osteoporosis in cellular models, highlighting the potential therapeutic benefits of baicalein in bone health management (37, 38). This evidence concerns the gene FOXO1 and osteoporosis.